GSTM1 and anemia: While such thresholds remain largely unexplored in high‐altitude settings, this approach has shown value in other clinical contexts, such as chronic kidney disease or heart failure, where anemia management is increasingly guided by symptom burden and functional outcomes rather than fixed Hb cutoffs alone [93].